451 related articles for article (PubMed ID: 8840974)
1. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.
Boyer SN; Wazer DE; Band V
Cancer Res; 1996 Oct; 56(20):4620-4. PubMed ID: 8840974
[TBL] [Abstract][Full Text] [Related]
2. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
3. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein.
Kamio M; Yoshida T; Ogata H; Douchi T; Nagata Y; Inoue M; Hasegawa M; Yonemitsu Y; Yoshimura A
Oncogene; 2004 Apr; 23(17):3107-15. PubMed ID: 15021916
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.
Berezutskaya E; Yu B; Morozov A; Raychaudhuri P; Bagchi S
Cell Growth Differ; 1997 Dec; 8(12):1277-86. PubMed ID: 9419416
[TBL] [Abstract][Full Text] [Related]
5. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7.
Sdek P; Zhang ZY; Cao J; Pan HY; Chen WT; Zheng JW
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):653-7. PubMed ID: 16513324
[TBL] [Abstract][Full Text] [Related]
6. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells.
Banks L; Edmonds C; Vousden KH
Oncogene; 1990 Sep; 5(9):1383-9. PubMed ID: 2216461
[TBL] [Abstract][Full Text] [Related]
7. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
8. P19ARF inhibits the functions of the HPV16 E7 oncoprotein.
Pan W; Datta A; Adami GR; Raychaudhuri P; Bagchi S
Oncogene; 2003 Aug; 22(35):5496-503. PubMed ID: 12934109
[TBL] [Abstract][Full Text] [Related]
9. Role of the ubiquitin/proteasome system in regulated protein degradation in Saccharomyces cerevisiae.
Smith SE; Koegl M; Jentsch S
Biol Chem; 1996; 377(7-8):437-46. PubMed ID: 8922277
[TBL] [Abstract][Full Text] [Related]
10. The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability.
Stöppler H; Stöppler MC; Adduci A; Koval D; Schlegel R
Virology; 1996 Mar; 217(2):542-53. PubMed ID: 8610446
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression.
Seewaldt VL; Dietze EC; Johnson BS; Collins SJ; Parker MB
Cell Growth Differ; 1999 Jan; 10(1):49-59. PubMed ID: 9950218
[TBL] [Abstract][Full Text] [Related]
12. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
[TBL] [Abstract][Full Text] [Related]
13. The role of the ubiquitin-proteasome pathway in apoptosis.
Orlowski RZ
Cell Death Differ; 1999 Apr; 6(4):303-13. PubMed ID: 10381632
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system.
Scheffner M; Whitaker NJ
Semin Cancer Biol; 2003 Feb; 13(1):59-67. PubMed ID: 12507557
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2).
Rockwell P; Yuan H; Magnusson R; Figueiredo-Pereira ME
Arch Biochem Biophys; 2000 Feb; 374(2):325-33. PubMed ID: 10666314
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
17. Degradation of Id proteins by the ubiquitin-proteasome pathway.
Bounpheng MA; Dimas JJ; Dodds SG; Christy BA
FASEB J; 1999 Dec; 13(15):2257-64. PubMed ID: 10593873
[TBL] [Abstract][Full Text] [Related]
18. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.
Gonzalez SL; Stremlau M; He X; Basile JR; Münger K
J Virol; 2001 Aug; 75(16):7583-91. PubMed ID: 11462030
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.
Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K
J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271
[TBL] [Abstract][Full Text] [Related]
20. The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome.
Berezutskaya E; Bagchi S
J Biol Chem; 1997 Nov; 272(48):30135-40. PubMed ID: 9374493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
